“…In the study by Zouari and colleagues and also other researchers, there is no clear message to give the readers regarding the treatment of AHC disease. In our experience, the treatment of AHC is determined by factors such as the presence of other organs of interest that is affected by the hydatid disease, the size of the AHCs, the involvement of the adjacent organs, radiologic stage, and the complications of the AHC disease (such as rupture, fistulization, hypertension, pheochromocytoma and related symptoms) [ 4 , 9 ].…”